Following on from GenomicsKate — and this may be the naive question:
How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?
Following on from GenomicsKate — and this may be the naive question:
How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?
quinn_sf said:If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.
This is where I part company with the consensus forming above. Filing an objection on the n=1 problem. Personal experience is genuine evidence about one person and very weak evidence about anybody else, and this thread keeps promoting the first into the second.
quinn_sf said:If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.
That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference Standardsquinn_sf said:If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.
Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.
Reporting back.
Six weeks on from posting: I stopped reading the weekly number and started reading a four-week average, and the "stall" I opened this thread about was a 1.8kg loss I could not see.